CLINICAL STUDIES
Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries
Barbara K. Julius, MD*,
Giuseppe Vassalli, MD*,
Lazar Mandinov, MD and
Otto M. Hess, MD
* Department of Internal Medicine, Cardiology, University Hospital, Zurich, Switzerland
Department of Internal Medicine, Cardiology, Inselspital, Bern, Switzerland
Manuscript received May 19, 1998;
revised manuscript received October 29, 1998,
accepted January 20, 1999.
Reprint requests and correspondence: Dr. Otto M. Hess, Professor of Cardiology, Swiss Heart Center, Inselspital, 3010 Bern, Switzerland
OBJECTIVES
The study aimed to evaluate the role of alpha-adrenergic mechanisms during dynamic exercise in both normal and stenotic coronary arteries.
BACKGROUND
Paradoxical vasoconstriction of stenotic coronary arteries has been reported during dynamic exercise and may be due to several factors such as alpha-adrenergic drive, a decreased release of nitric oxide, platelet aggregation with release of serotonin, or a passive collapse of the vessel wall.
METHODS
Twenty-six patients were studied at rest, during two levels of supine bicycle exercise and after 1.6 mg sublingual nitroglycerin. The alpha-blocker phentolamine was given to 16 patients before exercise, five of whom had also taken a beta-adrenergic-blocker the same morning. Ten patients served as controls. The cross-sectional areas of a normal and a stenotic coronary vessel were determined by biplane quantitative coronary arteriography.
RESULTS
In the normal vessel segments, coronary cross-sectional area did not change after phentolamine injection, but increased in all patient groups similarly during exercise. Although coronary vasoconstriction existed in stenotic vessel segments in control patients, phentolamine-treated patients showed exercise-induced vasodilation without difference in patients with and without chronic beta-blockade.
CONCLUSIONS
Exercise-induced vasoconstriction of stenotic coronary arteries is prevented by intracoronary administration of phentolamine. There was no difference in coronary vasomotion between patients receiving phentolamine alone and patients receiving phentolamine in addition to a beta-blocker. This finding suggests that exercise-induced vasoconstriction is mediated not only by endothelial dysfunction but also by alpha-adrenergic mechanisms.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | C | = controls | | CSA | = cross-sectional area | | NS | = not significant | | P | = patients receiving intracoronary phentolamine | P( ) | = patients receiving only phentolamine | | P( + ß) | = patients on chronic beta-blockade receiving phentolamine | | SD | = standard deviation |
|
This article has been cited by other articles:
|
|
|
|
 
E. Barbato
Role of adrenergic receptors in human coronary vasomotion
Heart,
April 1, 2009;
95(7):
603 - 608.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Flammer, F. Hermann, I. Sudano, L. Spieker, M. Hermann, K. A. Cooper, M. Serafini, T. F. Luscher, F. Ruschitzka, G. Noll, et al.
Dark Chocolate Improves Coronary Vasomotion and Reduces Platelet Reactivity
Circulation,
November 20, 2007;
116(21):
2376 - 2382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Barbato, F. Piscione, J. Bartunek, G. Galasso, P. Cirillo, G. De Luca, G. Iaccarino, B. De Bruyne, M. Chiariello, and W. Wijns
Role of {beta}2 Adrenergic Receptors in Human Atherosclerotic Coronary Arteries
Circulation,
January 25, 2005;
111(3):
288 - 294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Barbato, J. Bartunek, W. Aarnoudse, M. Vanderheyden, F. Staelens, W. Wijns, G. R. Heyndrickx, N. H.J. Pijls, and B. De Bruyne
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses
Eur. Heart J.,
November 2, 2004;
25(22):
2034 - 2039.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G. R. Heyndrickx, and B. De Bruyne
Effects of intravenous dobutamineon coronary vasomotion in humans
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1596 - 1601.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Heusch
Emerging importance of alpha-adrenergic coronary vasoconstriction in acute coronary syndromes and its genetic background
J. Am. Coll. Cardiol.,
January 15, 2003;
41(2):
195 - 196.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Sambuceti, M. Marzilli, S. Fedele, C. Marini, and A. L'Abbate
Paradoxical Increase in Microvascular Resistance During Tachycardia Downstream From a Severe Stenosis in Patients With Coronary Artery Disease : Reversal by Angioplasty
Circulation,
May 15, 2001;
103(19):
2352 - 2360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-M. Lee, S.-F. Su, W.-Y. Suo, C.-Y. Lee, M.-F. Chen, Y.-T. Lee, and C.-H. Tsai
Distension of urinary bladder induces exaggerated coronary constriction in smokers with early atherosclerosis
Am J Physiol Heart Circ Physiol,
December 1, 2000;
279(6):
H2838 - H2845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-M. Lee, S.-F. Su, M.-F. Chen, and C.-H. Tsai
Acute effects of urinary bladder distention on the coronary circulation in patients with early atherosclerosis
J. Am. Coll. Cardiol.,
August 1, 2000;
36(2):
453 - 460.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi
{alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans
Circulation,
February 15, 2000;
101(6):
689 - 694.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
